Vectus Biosystems Limited Stock: price and insider trades · Australia
Vectus Biosystems Limited: what insiders have been doing
Vectus Biosystems Limited belongs to the Health Care sector. Filings by its managers are published through ASX. From 24 October 2025 to 24 October 2026, the disclosure feed for Vectus Biosystems Limited logged 3 filings by 3 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 1,596 companies) published 4 filings over the same period, against 3 filings here.
Insider buying of Vectus Biosystems Limited has been absent for the past year.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- 0@ A$0.1850.78% mcap100.0% of flowShareASXASX:2924-03131980-2A1695238
- ShareASXASX:2924-03095409-2A1674655
- ShareASXISIN AU000000VBS9ASX:2924-03094637-2A1674232
3 of 3 declarations
About Vectus Biosystems Limited
Vectus Biosystems Limited is a company listed on the XASX, specializing in the development of biopharmaceutical solutions. It focuses on research and innovation in the field of medical treatments.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
